1. Cairns, J. Providing guidance to the NHS: The Scottish Medicines Consortium and the National Institute for Clinical Excellence compared. Health Policy. 2006;76:134–143.
2. Daniels, N, Sabin, J. The ethics of accountability in managed care reform. Health Aff (Millwood). 1998;17:50–64.
3. Daniels, N, Sabin, J. Setting limits fairly: Can we learn to share medical resources. New York: Oxford University Press; 2002.
4. Daniels, N, Sabin, JE. Setting limits fairly: Learning to share resources for health. New York: Oxford University Press; 2008.
5. Gibson, JL, Martin, DK, Singer, PA. Priority setting for new technologies in medicine: A transdisciplinary study. BMC Health Serv Res. 2002;2:14.
6. Golan, O. Ethical criteria for prioritization of medical services. J Health Law Bioeth. 2008;1:22–64.
7. Guttman, N, Shalev, C, Kaplan, G, et al. What should be given a priority - costly medications for relatively few people or inexpensive ones for many? The Health Parliament public consultation initiative in Israel. Health Expect. 2008;11:177–188.
8. Hammerman, A, Greenberg, D. Estimating the budget impact of new technologies added to the National List of Health Services in Israel: Stakeholders' incentives for adopting a financial risk-sharing mechanism. Health Policy. 2009;89:78–83.
9. Israeli State Controller and Ombudsman. Annual report for the year of 2003 and financial year of 2002 (Report 54b). Jerusalem: State of Israel; 2004.
10. Jansson, S. Implementing accountability for reasonableness-the case of pharmaceutical reimbursement in Sweden. Health Econ Policy Law. 2007;2:153–171.
11. Kapiriri, L, Norheim, OF, Martin, DK. Priority setting at the micro-, meso- and macro-levels in Canada, Norway and Uganda. Health Policy. 2007;82:78–94.
13. Menon, D, Stafinski, T, Martin, D. Priority-setting for healthcare: Who, how, and is it fair? Health Policy. 2007;84:220–233.
14. Mitton, CR, McMahon, M, Morgan, S, Gibson, J. Centralized drug review processes: Are they fair? Soc Sci Med. 2006;63:200–211.
15. Morgan, SG, MacMahon, M, Mitton, C, et al. Centralized drug review processes in Australia, Canada, New Zealand, and the United Kingdom. Health Aff (Millwood). 2006;25:337–347.
16. Neumann, PJ, Kamae, MS, Palmer, JA. Medicare's national coverage decisions for technologies, 1999–2007. Health Aff (Millwood). 2008;27:1–12.
18. Peacock, S, Ruta, D, Mitton, C, Donaldson, C, Bate, A, Murtagh, M. Using economics to set pragmatic and ethical priorities. BMJ. 2006;332:482–485.
19. Rabinovich, M, Wood, F, Shemer, J. Impact of new medical technologies on health expenditures in Israel 2000–2007. Int J Technol Assess Health Care. 2007;23:443–448.
20. Rocchi, A, Menon, D, Verma, S, Miller, E. The role of economic evidence in Canadian oncology reimbursement decision-making: The lambda and beyond. Value Health. 2008;11:771–783.
21. Rosen, B. In: Thompson, S, Mossialos, E, eds. Health care systems in transition: Israel. Copenhagen: European Observatory on Health Care Systems; 2003.
22. Schlander, M. NICE accountability for reasonableness: A qualitative study of its appraisal of treatments for attention-deficit/hyperactivity disorder (ADHD). Curr Med Res Opin. 2007;23:207–222.
23. Schreyögg, J, Stargardt, T, Velasco-Garrido, M, Busse, R. Defining the “Health Benefit Basket” in nine European countries. Evidence from the European Union Health BASKET Project. Eur J Health Econ. 2005;(Suppl):2–10.
24. Shalev, C, Chinitz, D. Joe public v. the general public: The role of the courts in Israeli health care policy. J Law Med Ethics. 2005;33:650–659.
25. Shani, S, Siebzehner, MI, Luxenburg, O, Shemer, J. Setting priorities for the adoption of health technologies on a national level – the Israeli experience. Health Policy 2000;54:169–185.
26. Shemer, J, Morginstin, T, Hammerman, A, Luxenburg, O, Shani, S. [Promoting medical technologies in the national list of health services: 1995–2000]. Harefuah. 2003;142:82–86.
27. Shmueli, A. Survival vs. quality of life: A study of the Israeli public priorities in medical care. Soc Sci Med. 1999;49:297–302.
28. Siebzehner, MI. Priority setting in medical technology-evaluation of the Israeli model. PhD thesis. Beer-Sheva: Ben-Gurion University of the Negev; 2004.
29. Steinbrook, R. Saying no isn't NICE- the travails of Britain's National Institute for Health and Clinical Excellence. N Engl J Med. 2008;359:1977–1981.
30. Tamir, O, Rabinovich, M, Shani, M. Year 2006 update of the Israel National List of Health Services. Isr Med Assoc J. 2006; 8:595–600.
31. Victoria Israeli and others vs. PNAC and others High Court of Justice Judgment of 11 June 2006: 2974/06. Available from: http://www.courts.co.il/